83
Participants
Start Date
November 29, 2022
Primary Completion Date
November 30, 2024
Study Completion Date
October 31, 2025
Arterial chemoembolization
The blood supplying artery of the tumor is selected for drug injection with Oxaliplatin 85mg/m2 combined Raltitrexed 3mg/m2. After drug injection, gelatin sponge is used for embolization.
Tislelizumab Injection
Tislelizumab Injection 200mg i.v. q3w, A total of 3 cycles are administered.
XELOX
Capecitabine 1,000 mg/m2 bid, po, on days 1-14 Oxaliplatin: 130 mg/m2, i.v. day 1 Cycles are repeated on day 22. A total of 3 cycles are administered.
Pelvic MRI
Pelvic MRI to evaluate efficacy
Laparoscopic radical resection of rectal cancer
Surgical treatment for patients who meet the surgical conditions
RECRUITING
The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
OTHER